 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Albert David Standalone September 2023 Net Sales at Rs 93.18 crore, up 0.86% Y-o-Y

Albert David Standalone March 2023 Net Sales at Rs 81.42 crore, up 9.48% Y-o-Y

Albert David Standalone December 2022 Net Sales at Rs 74.57 crore, up 4% Y-o-Y

Albert David also appointed A B Chakrabartty as the company secretary & compliance officer cum legal head of the company with effect from 4 February 2023. Kolkata-based Albert David is a pharmaceutical company. Its net profit rose 58.96% to Rs 20.14 crore on 7% rise in net sales to Rs 92.38 crore in Q2 September 2022 over Q2 September 2021. Shares of Albert David ended flat at Rs 550 on Friday, 3 February 2023.

Albert David appoints Umesh Kunte as CEO

Albert David Ltd. engages in the manufacturing and trade of pharmaceuticals. Its products include a range of formulations, infusion solutions, bulk drugs, disposable syringes, and disposable needles. The company was founded in 1924 and is headquartered in Kolkata, India.

Market Cap	5.87B
Volume (M)	21,872.00
52-Wk High	1,092.00
52-Wk Low	505.95

ALBERTDAVD.NSE Albert David Ltd.

About

Feed

News

Fundamentals